MUTATIONAL ANALYSIS OF HUMAN PAPILLOMAVIRUS TYPE-16 E6 PROTEIN - TRANSFORMING FUNCTION FOR HUMAN-CELLS AND DEGRADATION OF P53 IN-VITRO

被引:63
作者
NAKAGAWA, S
WATANABE, S
YOSHIKAWA, H
TAKETANI, Y
YOSHIIKE, K
KANDA, T
机构
[1] NIH, DIV MOLEC GENET, SHINJUKU KU, TOKYO 162, JAPAN
[2] UNIV TOKYO, FAC MED, DEPT OBSTET & GYNECOL, BUNKYO KU, TOKYO 113, JAPAN
关键词
D O I
10.1006/viro.1995.1511
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The E6 oncoprotein of human papillomavirus type 16(HPV 16) [151 amino acids (AA) long] contains four metal-binding motifs, C-X-X-C, and is postulated to form two 29-AA finger-like structures in the N-terminal and C-terminal halves, which mediate degradation of p53 and binding to p53, respectively. We constructed a series of E6 mutants with single-AA substitutions in these finger regions (AAs 34-62 and 107-135) and examined their transforming function for human embryonic kidney (HEK) cells in conjunction with HPV 16 E7 and their interaction with human p53 in vitro. The mutants with substitution of L for F-37, G for L-50, S for Y-54, and P for L-110, which did not transform HEK cells, showed markedly lowered activity to direct degradation of p53. The mutants with substitutions of G for R-39, G for V-42, G for Y-43, L for F-47, and G for V-53 lost the transforming function, but they could mediate degradation of p53 at levers comparable to the activities of the wild-type and transforming mutants. Like the wild type, all of the E6 mutants were localized by immunofluorescence to the nuclei of human TS21B cells or monkey COS-I cells, except for the E6 mutant with substitution of G for Y-43 whose expression was undetectable. The levels of E6 mutants metabolically labeled in COS-l cells were comparable to those of the transforming E6s. The data indicate that EG-directed degradation of p53 is necessary but not sufficient for HPV 18-mediated transformation of HEK cells. (C) 1995 Academic Press, Inc.
引用
收藏
页码:535 / 542
页数:8
相关论文
共 49 条
[1]   IDENTIFICATION OF THE HPV-16 E6 PROTEIN FROM TRANSFORMED MOUSE CELLS AND HUMAN CERVICAL-CARCINOMA CELL-LINES [J].
ANDROPHY, EJ ;
HUBBERT, NL ;
SCHILLER, JT ;
LOWY, DR .
EMBO JOURNAL, 1987, 6 (04) :989-992
[2]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[3]   THE REGION OF THE HPV E7 ONCOPROTEIN HOMOLOGOUS TO ADENOVIRUS E1A AND SV40 LARGE T-ANTIGEN CONTAINS SEPARATE DOMAINS FOR RB BINDING AND CASEIN KINASE-II PHOSPHORYLATION [J].
BARBOSA, MS ;
EDMONDS, C ;
FISHER, C ;
SCHILLER, JT ;
LOWY, DR ;
VOUSDEN, KH .
EMBO JOURNAL, 1990, 9 (01) :153-160
[4]   THE E2F TRANSCRIPTION FACTOR IS A CELLULAR TARGET FOR THE RB PROTEIN [J].
CHELLAPPAN, SP ;
HIEBERT, S ;
MUDRYJ, M ;
HOROWITZ, JM ;
NEVINS, JR .
CELL, 1991, 65 (06) :1053-1061
[5]   NUCLEOTIDE-SEQUENCE AND COMPARATIVE-ANALYSIS OF THE HUMAN PAPILLOMAVIRUS TYPE-18 GENOME - PHYLOGENY OF PAPILLOMAVIRUSES AND REPEATED STRUCTURE OF THE E6 AND E7 GENE-PRODUCTS [J].
COLE, ST ;
DANOS, O .
JOURNAL OF MOLECULAR BIOLOGY, 1987, 193 (04) :599-608
[6]   CONTINUED EXPRESSION OF HPV-16 E7 PROTEIN IS REQUIRED FOR MAINTENANCE OF THE TRANSFORMED PHENOTYPE OF CELLS CO-TRANSFORMED BY HPV-16 PLUS EJ-RAS [J].
CROOK, T ;
MORGENSTERN, JP ;
CRAWFORD, L ;
BANKS, L .
EMBO JOURNAL, 1989, 8 (02) :513-519
[7]   DEGRADATION OF P53 CAN BE TARGETED BY HPV E6 SEQUENCES DISTINCT FROM THOSE REQUIRED FOR P53 BINDING AND TRANSACTIVATION [J].
CROOK, T ;
TIDY, JA ;
VOUSDEN, KH .
CELL, 1991, 67 (03) :547-556
[8]   INFLUENCE OF CHROMOSOMAL INTEGRATION ON GLUCOCORTICOID-REGULATED TRANSCRIPTION OF GROWTH-STIMULATING PAPILLOMAVIRUS GENES E6 AND E7 IN CERVICAL-CARCINOMA CELLS [J].
DOEBERITZ, MV ;
BAUKNECHT, T ;
BARTSCH, D ;
HAUSEN, HZ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1411-1415
[9]   THE HUMAN PAPILLOMA VIRUS-16 E7-ONCOPROTEIN IS ABLE TO BIND TO THE RETINOBLASTOMA GENE-PRODUCT [J].
DYSON, N ;
HOWLEY, PM ;
MUNGER, K ;
HARLOW, E .
SCIENCE, 1989, 243 (4893) :934-937
[10]   WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
ELIYAHU, S ;
PINHASIKIMHI, O ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8763-8767